Search research articles
Contact Us
Filters
Showing results (141-150 of 152) with videos related to
Page
of 16
Sort By:
The Journal of Biological Chemistry
|
August 12, 2011
Neuroprotection against traumatic brain injury by a peptide derived from the collapsin response mediator protein 2 (CRMP2)
Joel M Brittain, Liang Chen, Sarah M Wilson, et al.
Behavioural Brain Research
|
June 7, 2021
Psychosocial impairment following mild blast-induced traumatic brain injury in rats
Nicholas S Race, Katharine D Andrews, Elizabeth A Lungwitz, et al.
Journal of Clinical and Translational Science
|
May 5, 2021
The Access Technology Program of the Indiana Clinical Translational Sciences Institute (CTSI): A model to facilitate access to cutting-edge technologies across a state
Christie M Orschell, Todd C Skaar, Melanie E DeFord, et al.
Nature Reviews. Drug Discovery
|
December 29, 2018
The first implementation of the NIMH FAST-FAIL approach to psychiatric drug development
Andrew D Krystal, Diego A Pizzagalli, Sanjay J Mathew, et al.
Nature Neuroscience
|
September 23, 2014
Social learning and amygdala disruptions in Nf1 mice are rescued by blocking p21-activated kinase
Andrei I Molosh, Philip L Johnson, John P Spence, et al.
Depression and Anxiety
|
May 11, 2010
Multicenter, randomized, double-blind, active comparator and placebo-controlled trial of a corticotropin-releasing factor receptor-1 antagonist in generalized anxiety disorder
Vladimir Coric, Howard H Feldman, Dan A Oren, et al.
Translational Psychiatry
|
September 8, 2020
Translational evaluation of novel selective orexin-1 receptor antagonist JNJ-61393215 in an experimental model for panic in rodents and humans
Giacomo Salvadore, Pascal Bonaventure, Anantha Shekhar, et al.
Science Translational Medicine
|
October 13, 2021
Ubiquitination and degradation of SUMO1 by small-molecule degraders extends survival of mice with patient-derived tumors
Anita C Bellail, Hong Ri Jin, Ho-Yin Lo, et al.
Journal of American College Health : J of ACH
|
January 3, 2023
SARS-CoV-2 control on a large urban college campus without mass testing
Christopher O'Donnell, Katherine Brownlee, Elise Martin, et al.
Nature Medicine
|
June 7, 2011
Suppression of inflammatory and neuropathic pain by uncoupling CRMP-2 from the presynaptic Ca²⁺ channel complex
Joel M Brittain, Djane B Duarte, Sarah M Wilson, et al.
Page
of 16
Search research articles
Search
Showing results (141-150 of 152) with videos related to
Sort By:
Page
of 16
The Journal of Biological Chemistry
|
August 12, 2011
Neuroprotection against traumatic brain injury by a peptide derived from the collapsin response mediator protein 2 (CRMP2)
Joel M Brittain, Liang Chen, Sarah M Wilson, et al.
Behavioural Brain Research
|
June 7, 2021
Psychosocial impairment following mild blast-induced traumatic brain injury in rats
Nicholas S Race, Katharine D Andrews, Elizabeth A Lungwitz, et al.
Journal of Clinical and Translational Science
|
May 5, 2021
The Access Technology Program of the Indiana Clinical Translational Sciences Institute (CTSI): A model to facilitate access to cutting-edge technologies across a state
Christie M Orschell, Todd C Skaar, Melanie E DeFord, et al.
Nature Reviews. Drug Discovery
|
December 29, 2018
The first implementation of the NIMH FAST-FAIL approach to psychiatric drug development
Andrew D Krystal, Diego A Pizzagalli, Sanjay J Mathew, et al.
Nature Neuroscience
|
September 23, 2014
Social learning and amygdala disruptions in Nf1 mice are rescued by blocking p21-activated kinase
Andrei I Molosh, Philip L Johnson, John P Spence, et al.
Depression and Anxiety
|
May 11, 2010
Multicenter, randomized, double-blind, active comparator and placebo-controlled trial of a corticotropin-releasing factor receptor-1 antagonist in generalized anxiety disorder
Vladimir Coric, Howard H Feldman, Dan A Oren, et al.
Translational Psychiatry
|
September 8, 2020
Translational evaluation of novel selective orexin-1 receptor antagonist JNJ-61393215 in an experimental model for panic in rodents and humans
Giacomo Salvadore, Pascal Bonaventure, Anantha Shekhar, et al.
Science Translational Medicine
|
October 13, 2021
Ubiquitination and degradation of SUMO1 by small-molecule degraders extends survival of mice with patient-derived tumors
Anita C Bellail, Hong Ri Jin, Ho-Yin Lo, et al.
Journal of American College Health : J of ACH
|
January 3, 2023
SARS-CoV-2 control on a large urban college campus without mass testing
Christopher O'Donnell, Katherine Brownlee, Elise Martin, et al.
Nature Medicine
|
June 7, 2011
Suppression of inflammatory and neuropathic pain by uncoupling CRMP-2 from the presynaptic Ca²⁺ channel complex
Joel M Brittain, Djane B Duarte, Sarah M Wilson, et al.
Page
of 16